Preclinical Imaging Webinars
Preclinical Imaging Webinars
In this webinar, Dr. Jason Otterstrom and Dr. Alexandra Lubin will describe the AI-powered analysis platform their teams have developed, highlighting a range of applications validating its performance. In brief, the easy-to-use software automatically identifies the Zebrafish outline, and internal anatomy & body regions with no required user inputs.
Hyperpolarized 129Xe MRI has emerged as a powerful technique to evaluate lung function and has found clinical application in several disorders like asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and more.
Image reconstruction is a fundamental part of PET allowing to generate 3D tomographic images of the tracer’s spatial distribution based on the position and timing of the detected annihilation gammas.
Micro-computed tomography (micro-CT) offers significant advantages over other X-ray imaging techniques in the field of bone research.
Endodontics is a specialty within the field of dentistry concerned with the morphology, physiology and pathology of the human dental pulp and periradicular tissues.
In this webinar, Professor Greetje Vande Velde will give an overview of her work, which involves lung and brain infections. Professor Vande Velde will describe how high-field MRI and low dose microCT complement each other; where microCT gives high contrast in the lungs and MRI allows clear visualization of the brain.
In this webinar, Dr. Dane Maxfield discusses the benefits of light-sheet fluorescence microscopy as a gentle bio-imaging technique for imaging a wide range of biological samples with high spatial and temporal resolution
Getting a good microCT image of your animal’s bone, in vivo or ex vivo, is just the start. To realize the goals of your preclinical study, quantitative outcomes are needed.
The researchers will discuss the use of rabiolabeled siderophores in the detection of Aspergillus fumigatus, a fungus that causes the life-threatening infection invasive aspergillosis (IA). Early and accurate detection of Aspergillus infection is crucial, but current methods lack sufficient specificity and/or sensitivity.
In ovo MRI is a preclinical imaging technique in oncology research that involves the study of chicken egg embryos and a structure called the chorioallantoic membrane (CAM). The CAM is a highly vascularized and specialized tissue that performs various functions during embryonic development. The CAM model is a simple, low-cost and highly effective tool in the study of tumor angiogenesis, tumor growth, metastasis and cancer treatment; processes that can all be non-invasively monitored using MRI. I
The Bruker Si PET technology is the first of its kind to deliver real, homogeneous submillimetric volumetric PET resolution in all three axes in the whole field of view.
Combining preclinical in vivo imaging modalities offers the opportunity to synergize the strengths of each in one experiment. For example, optical imaging offers the ability to non-invasively and longitudinally track molecular and cellular events, frequently using bioluminescence or fluorescence genetic reporters.
Small animal pre-clinical imaging is a vital tool in the field of biomedical research, allowing the study of biological processes and potential diagnostic or therapeutic agents in living animals.
In this webinar, Dr. Julien Flament of Molecular Imaging Research Center (MIRCen, CEA), Fontenay-aux-Roses, France, will present an introduction to the theoretical background of Chemical Exchange Saturation Transfer (CEST) imaging and its potential in neurodegenerative disease research.
In vivo imaging is at the heart of preclinical research into cancer biology and treatment, with advances in technology delivering tools that are ever more powerful, accurate and easy-to-use.
Bruker’s new SkyScan 1276 in vivo microCT combines high-resolution, speed, accessibility and innovation to uphold improved in vivo scanning of small laboratory animals and biological samples in preclinical studies.
Due to its great versatility, MRI is a key tool of choice for critical preclinical research, e.g. oncology, cardiology, and neurology.
Glioblastome multiforme is the most common form of brain cancer and diagnosed patients have a life expectancy of less than two years. In spite of the fact that its diagnosis is very good, an appropriate treatment remains elusive.
Following the huge upsurge in interest in bringing imaging to new and wider areas of research, Bruker is not only seeking to support new multimodality approaches through its instrument portfolio, but has also completely redesigned its preclinical MRI software to offer enhanced productivity and multi-platform capability.